Senior Manager/Associate Director, Scientific Communications & Publications

USA (On-site)

$182K/yr – $226K/yrSenior Level6+ years expFull time

Posted 9 days ago

Job Summary

Own and drive publication strategy and execution for Medical Affairs programs, leading cross-functional teams and shaping major publication deliverables from abstracts to manuscripts in a fast-paced oncology setting.

Job Description

Responsibilities

  • Lead publication strategy and execution for assigned Medical Affairs programs, with responsibility for major publication deliverables and outcomes. As the Publications Lead, represent Scientific Communications and Publications on cross-functional teams and align publication priorities with program objectives, Medical Affairs strategy, and corporate goals. This role requires strong scientific judgment, publication expertise, stakeholder leadership, and the ability to manage complex deliverables in a fast-paced oncology environment.
  • Serve as Publications Lead for assigned programs, providing strategic guidance and representing Scientific Communications & Publications on cross-functional program teams
  • Lead planning, development, and execution of publication tactics including manuscripts, abstracts, posters, and oral presentations for assigned programs in accordance with company policies and procedures
  • Lead publication team meetings to drive strategic discussion, decision-making, and alignment
  • Apply independent judgment to manage complex deliverables, resolve stakeholder feedback, and escalate key risks or decisions as appropriate.
  • Contribute to Annual Strategic Publication Plans aligned with Medical Affairs strategy, program priorities, and corporate goals
  • Build and maintain effective relationships with internal stakeholders (program teams, clinical, medical, translational research) as well as external authors and KOLs
  • Support continuous improvement of publication processes, templates, and ways of working to improve efficiency, consistency, and compliance
  • Manage scientific platform development and updates for assigned programs as needed
  • Oversee publication vendors/agencies, including scopes of work, timelines, deliverables, and budgets

Requirements

  • Advanced scientific degree (PharmD or PhD preferred)
  • A minimum of 6-8 years of direct publications experience in the pharmaceutical or biotech industry
  • Demonstrated ability to lead development of abstracts, posters, oral presentations, manuscripts, slide decks, and other medical/scientific content
  • Strong scientific acumen and ability to translate complex data into clear, accurate, and strategically relevant communications
  • Demonstrated poise and judgement in aligning internal and external stakeholders (eg, authors, cross-functional teams, researchers, journal editors)
  • Ability to critically review and edit publication documents for quality, compliance, and scientific integrity
  • Excellent verbal and written communication skills; strong project management skills
  • Ability to manage multiple projects, anticipate risks, and drive deliverables in a dynamic, fast-paced environment
  • Exercises independent judgment in managing operational decisions within their area; proactively identifies issues and determines when to escalate more complex or cross-functional decisions.
  • Serves as a key point of contact for cross-functional partners within their area, ensuring alignment and proactively addressing coordination needs to support team deliverables.

Preferred

  • Oncology and/or Hematology experience is highly preferred
  • CMPP certification preferred

Benefits

  • Generous Benefits Package with a variety of plans available with a substantial employer match
  • 401K + Employer contributions
  • Generous stock options
  • ESPP Plan
  • Paid Paternity/Maternity Leave
  • In-Office Catered lunches
  • Home Office Setup
  • Lifestyle Spending Stipend
  • Commuter Stipend (Boston Office)
  • 20 days of PTO to start
Kura Oncology, Inc. logo

Kura Oncology, Inc.

3.4 Glassdoor

Kura Oncology is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. Our small-molecule drug candidates target signaling pathways and other drivers of cancer where there is a strong scientific and clinical rationale to improve outcomes by identifying those patients most likely to benefit from treatment. Kura’s pipeline consists of three investigational drug candidates: ziftomenib, tipifarnib and KO-2806. Ziftomenib is a once-daily, oral drug candidate targeting the menin-KMT2A protein-protein interaction for the treatment of genetically defined AML patients with high unmet need. Ziftomenib is currently enrolling patients in a Phase 2 registration-directed trial (KOMET-001) in NPM1-mutant relapsed or refractory AML. Kura is preparing to initiate multiple Phase 1 trials to evaluate ziftomenib in combination with current standards of care in earlier lines of therapy and across multiple patient populations, including NPM1-mutant and KMT2A-rearranged AML. Tipifarnib, a potent and selective FTI, is currently in a Phase 1/2 trial (KURRENT-HN) in combination with alpelisib for patients with PIK3CA-dependent HNSCC. Kura intends to evaluate KO-2806, a next-generation FTI, in a Phase 1 dose-escalation trial (FIT-001) as a monotherapy and in combination with other targeted therapies in adult patients with advanced solid tumors. For additional information, please visit Kura’s website at www.kuraoncology.com.

Founded in 2014
San Diego, California, USA
304 employees (22 in marketing)
60% recommend to a friend

Salaries

Posted range

$182K/yr – $226K/yr

Taken straight from the job posting.

Communications median pay in the United States

$93K/yr

Most pay falls between $70K and $136K. Based on 6,143 salaries.

See all Kura Oncology, Inc. salaries

Marketing Team

Marketing Team Size
21 (7% of company)
Median Career Experience
8 years
Median Tenure
2.2 years
Marketing Roles Posted (Last 30 Days)
1

Funding

Total Funding
$1.2B
Last Raise
$150M
Post IPO Equity, 2 years ago

Funding History

  • Jan 2024
    Post IPO Equity • $150M
  • Jun 2023
    Post IPO Equity • $100M
  • Nov 2022
    Post IPO Debt • $125M

Traffic Signals

Monthly Visitors
10.3K
Monthly Google Ads Budget
$40
Traffic Source Mix
Search
39.4%
Direct
44.2%
Referral
6.1%
Social
8.7%
Paid
1.5%

Headcount Trend

Current headcount: ~304